NIH-funded research R01 grant

Understanding How Some Brains Resist Alzheimer's Disease

Official title: Cell Type-Specific Proteins that Promote Resilience to Cognitive Aging and Alzheimer's Disease

Funded at University of Michigan at Ann Arbor · NIH-11099953 · Data updated 2026-11-12

This research looks for natural protective factors in the brain that help some people maintain their thinking skills even as they age or develop early signs of Alzheimer's disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startSeptember 30, 2021
Project endMay 31, 2027
Funding year2025
Award (this year)$1,284,306
NIH project number5R01AG075818-05
Project IDNIH-11099953 on NIH RePORTER

Who could benefit from this research

Could help

This foundational research does not directly involve patient participation at this stage, but future clinical applications would target individuals at risk for or in early stages of Alzheimer's disease.

Less likely to help

Patients seeking immediate treatment or direct clinical intervention will not receive benefit from this early-stage discovery research.

What this research studies

We know that some individuals maintain sharp minds despite aging or even having changes in their brain linked to Alzheimer's. This project aims to discover the specific proteins within different brain cells that provide this natural protection. By studying these protective factors, we hope to find new ways to prevent or treat Alzheimer's disease. This work uses advanced methods with animal models to identify these key proteins, which could then be explored for human benefit.

Why it matters

Potential benefit: If successful, this research could identify new targets for developing treatments or preventive strategies for Alzheimer's disease and cognitive decline.

How similar studies have gone: While the concept of resilience to Alzheimer's is recognized, this specific approach to identify cell type-specific protective proteins using advanced proteomic techniques in longitudinal models is innovative.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Kaczorowski, Catherine Cook — University of Michigan at Ann Arbor
  • Study coordinator: Kaczorowski, Catherine Cook

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.